Kangmei Pharma | 600518 - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 25.02M 2.36M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Dianthus Therapeutics USD 1.17B 29.29M 2026-06
Genomma Lab Internacional MXN 11.78B 61.22M 2026-06
Hypermarcas BRL 14.12B 1.6B 2026-03
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Jiangsu Hengrui CNY 64.47B 840.17M 2026-06
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Moderna USD 6.76B 647M 2026-06
Organon & Co USD 1.01B 103M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Sh Fosun Pharma CNY 49.15B 248.15M 2026-03
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Viatris USD 14.26B 397.3M 2026-06
Wuxi Apptec CNY 83.33B 1.44B 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03